#$%^&*AU2014201765B220151210.pdf#####ABSTRACT Disclosed herein are methods of treating pulmonary disorders comprising administering to the patient an effective dose of a nebulized liposomal amikacin formulation for at least one treatment cycle, wherein: the treatment cycle comprises an administration period of 15 to 75 days, followed by an off period of 15 to 75 days and the effective dose comprises 100 to 2500 mg of amikacin daily during the administration period.